相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vitro Characterization and Pharmacokinetics of Dapagliflozin (BMS-512148), a Potent Sodium-Glucose Cotransporter Type II Inhibitor, in Animals and Humans
M. Obermeier et al.
DRUG METABOLISM AND DISPOSITION (2010)
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
Clifford J. Bailey et al.
LANCET (2010)
Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
B. Komoroski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Evolution of sodium glucose co-transporter 2 inhibitors as anti-diabetic agents
William N. Washburn
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
Applying the biopharmaceutics classification system to veterinary pharmaceutical products Part II. Physiological considerations
M Martinez et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
A mechanistic approach to understanding the factors affecting drug absorption: A review of fundamentals
MN Martinez et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
分享论文
